Understanding Diabetic Ketoacidosis in Pregnancy

Diabetic ketoacidosis (DKA) is a life-threatening metabolic emergency that demands immediate recognition and intervention, and this risk is amplified during pregnancy. For pregnant women with preexisting type 1 diabetes, type 2 diabetes, or even gestational diabetes, the physiological changes of gestation can accelerate the progression from hyperglycemia to full-blown ketoacidosis. DKA in pregnancy threatens both maternal and fetal wellbeing, with potential consequences including preterm labor, fetal hypoxia, and, in severe cases, maternal or fetal death. Early identification of symptoms is the single most powerful tool for improving outcomes.

Unlike non-pregnant adults, pregnant women can develop DKA at relatively modest blood glucose levels—sometimes below 200 mg/dL—because of the metabolic shifts unique to gestation. This phenomenon, sometimes called euglycemic DKA, makes symptom recognition even more critical. Waiting for a strikingly high glucose reading before suspecting DKA can delay treatment and increase risk.

Pathophysiology: Why Pregnancy Increases DKA Risk

Pregnancy induces a state of accelerated starvation and insulin resistance. The placenta produces human placental lactogen, cortisol, and growth hormone, all of which antagonize insulin action. As gestational age advances, insulin sensitivity declines by 50 to 60 percent. At the same time, the growing fetus consumes glucose continuously, and the maternal liver increases gluconeogenesis. When insulin deficiency or resistance becomes severe, the body shifts to fat metabolism, producing ketone bodies—acetoacetate, beta-hydroxybutyrate, and acetone— faster than tissues can clear them. The resulting metabolic acidosis defines DKA.

Pregnant women also have a diminished respiratory buffer capacity due to the upward displacement of the diaphragm and a compensated respiratory alkalosis that is normal in pregnancy. Once acidosis begins, the ability to compensate is quickly overwhelmed. This metabolic instability means DKA can develop more rapidly in pregnant women than in non-pregnant individuals, sometimes within hours of a missed insulin dose or an intercurrent illness.

Core Symptoms of DKA in Pregnancy

The symptoms of DKA in pregnancy overlap with those in non-pregnant patients, but certain features may be masked or misinterpreted because they resemble common pregnancy discomforts. A high index of suspicion is essential. Below is a comprehensive breakdown of the clinical manifestations.

Hyperglycemia and Its Direct Effects

  • Markedly elevated blood glucose: Typically above 250 mg/dL, though euglycemic DKA can present with normal or mildly elevated values. Frequent monitoring is the only reliable way to detect this.
  • Polyuria (excessive urination): The kidneys attempt to excrete excess glucose, drawing water with it. Pregnant women already experience increased urinary frequency from uterine pressure; a sudden worsening may signal DKA.
  • Polydipsia (intense thirst) and dry mucous membranes: Dehydration from osmotic diuresis leads to persistent thirst that is not relieved by drinking. The mouth and skin may feel dry.
  • Blurred vision: Hyperglycemia causes osmotic shifts in the lens, temporarily altering refractive power. This symptom is often overlooked during pregnancy.

Gastrointestinal Symptoms

  • Nausea and vomiting: Among the earliest and most common signs. Vomiting worsens dehydration and electrolyte losses. In pregnancy, nausea is easily attributed to morning sickness, but persistent or severe vomiting demands evaluation.
  • Abdominal pain: Often diffuse, cramping, or severe. DKA can cause a clinical picture that mimics an acute abdomen, including tenderness and guarding. This pain may lead to unnecessary surgical evaluation if DKA is not considered.
  • Anorexia and general malaise: A loss of appetite combined with a sense of feeling unwell often precedes other symptoms.

Respiratory and Acid-Base Changes

  • Kussmaul respirations: Deep, rapid, sighing breaths are the body's attempt to blow off carbon dioxide and compensate for metabolic acidosis. This breathing pattern is unmistakable once recognized and should prompt immediate concern.
  • Fruity or acetone-scented breath: Accumulated acetone is exhaled, giving the breath a sweet, chemical odor. This is a classic hallmark of ketosis and is often noticeable by caregivers or clinicians.
  • Shortness of breath: Dyspnea can result from both acidotic respiratory drive and the mechanical effects of pregnancy on the diaphragm.

Neurologic and Systemic Symptoms

  • Fatigue and profound weakness: Muscle cells lose function in the acidotic environment. Patients may report feeling unable to stand or hold up their head.
  • Headache: Dehydration and acidosis contribute to persistent, dull headaches.
  • Mental status changes: Difficulty concentrating, confusion, drowsiness, or agitation. In severe cases, obtundation or coma can develop. Any alteration in consciousness in a pregnant woman with diabetes should be treated as DKA until proven otherwise.
  • Hypotension and tachycardia: Volume depletion from dehydration reduces cardiac output and triggers a compensatory rapid heart rate. Blood pressure may drop, especially upon standing.

Fetal Signs

The mother is not the only patient. The fetus responds to maternal acidosis and hyperglycemia with compensatory changes. Pregnant women may notice decreased fetal movement as acidosis worsens. Fetal tachycardia on monitoring is an early sign of distress. Late signs include loss of beat-to-beat variability or decelerations. Any concerning change in fetal activity warrants immediate evaluation.

Risk Factors Specific to Pregnant Women

Understanding which women are at highest risk can help focus preventive efforts and encourage vigilance. Key risk factors include:

  • Preexisting type 1 diabetes: Particularly in the second and third trimesters when insulin resistance peaks and the risk of insulin omission is greatest.
  • Gestational diabetes requiring insulin therapy: While less common, DKA can occur in gestational diabetes, especially when glycemic control is poor or insulin is discontinued.
  • Infection or febrile illness: Any infection—urinary tract infection, pneumonia, upper respiratory infection, or chorioamnionitis—increases counter-regulatory hormone release and can trigger DKA.
  • Use of beta-sympathomimetic medications: Drugs used for tocolysis (e.g., terbutaline) can raise blood glucose and precipitate DKA.
  • Corticosteroid administration for fetal lung maturity: Betamethasone or dexamethasone given in preterm labor dramatically elevates blood glucose and can destabilize metabolic control.
  • Insulin pump failure or missed insulin doses: Pregnant women using insulin pumps are at risk if the infusion set becomes occluded or dislodged.
  • Hyperemesis gravidarum: Severe vomiting reduces caloric intake, depletes fluids, and shifts metabolism toward ketogenesis.

Diagnostic Evaluation

Diagnosis of DKA in pregnancy relies on laboratory confirmation. The classic triad is hyperglycemia, ketosis, and metabolic acidosis. Diagnostic thresholds in pregnancy are the same as in non-pregnant adults, with the caveat that euglycemic DKA must be considered.

  • Blood glucose: Typically >250 mg/dL, but DKA can occur at lower values in pregnancy.
  • Serum ketones: Beta-hydroxybutyrate levels >3 mmol/L indicate significant ketosis.
  • Arterial or venous blood gas: pH <7.3 or bicarbonate <15 mEq/L confirms metabolic acidosis.
  • Anion gap: An elevated anion gap (>12 mEq/L) supports the diagnosis.
  • Electrolytes: Sodium may be low or normal; potassium is often elevated initially but can drop rapidly with treatment.
  • Complete blood count and infection workup: To identify precipitating infection.
  • Fetal assessment: Continuous fetal monitoring for heart rate abnormalities.

Bedside urine ketone dipsticks can provide rapid screening, but serum beta-hydroxybutyrate measurement is more accurate and preferred.

Treatment Principles in Pregnancy

Management of DKA in pregnancy requires a coordinated team approach involving maternal-fetal medicine specialists, endocrinologists, and critical care providers. The goals are to correct volume depletion, reduce hyperglycemia, clear ketones, restore acid-base balance, and identify and treat the underlying precipitant.

  • Intravenous fluid resuscitation: Normal saline is given to restore intravascular volume. Pregnant women require careful monitoring for fluid overload given the increased plasma volume of pregnancy and the risk of pulmonary edema.
  • Insulin therapy: Continuous intravenous infusion of regular insulin is the standard. The goal is to lower glucose by approximately 50-75 mg/dL per hour. Glucose targets in pregnancy are tighter; maintaining glucose between 100 and 150 mg/dL helps protect the fetal metabolic environment.
  • Potassium replacement: DKA causes total body potassium depletion despite an often normal or high serum level initially. Once insulin is started, potassium shifts intracellularly, and supplementation is almost always needed.
  • Bicarbonate therapy: Not routinely recommended unless severe acidosis (pH <7.0) threatens maternal cardiac function. Bicarbonate can worsen fetal hypercapnia and paradoxically lower cerebrospinal fluid pH.
  • Fetal monitoring: Continuous electronic fetal monitoring is essential. As the maternal metabolic state improves, fetal heart rate tracings typically normalize.

Complications of Untreated DKA in Pregnancy

Delayed recognition and treatment of DKA in pregnancy carries serious consequences for both mother and fetus. Maternal complications include:

  • Cerebral edema, especially in children and young adults, though rare in adults
  • Acute kidney injury from severe dehydration
  • Pulmonary edema from aggressive fluid resuscitation or underlying aspiration
  • Electrolyte disturbances leading to cardiac arrhythmias
  • Hypoglycemia from overcorrection once treatment begins

Fetal and neonatal complications are equally grave:

  • Intrauterine hypoxia and acidosis
  • Preterm labor and delivery
  • Low birth weight or intrauterine growth restriction
  • Neonatal respiratory distress syndrome and metabolic instability
  • Stillbirth, with fetal death rates historically reported at 9-36% in DKA episodes

When to Seek Immediate Medical Care

Every pregnant woman with diabetes should have a written action plan for hyperglycemia and illness. The following symptoms require immediate evaluation in a hospital setting:

  • Blood glucose persistently above 250 mg/dL despite corrective insulin doses
  • Moderate to large urine ketones that do not clear with supplemental insulin and fluids
  • Persistent vomiting or inability to keep down food or fluids for more than a few hours
  • Deep, rapid breathing or shortness of breath at rest
  • Fruity-smelling breath
  • Severe abdominal pain
  • Confusion, drowsiness, or difficulty staying awake
  • Decreased fetal movement compared to baseline patterns
  • Signs of infection such as fever, chills, or urinary symptoms

Women using insulin pumps should be educated on the signs of pump failure and how to check for ketones. If DKA is suspected, the pump should be disconnected and insulin administered by injection or intravenous infusion without delay.

Prevention Strategies

Preventing DKA in pregnancy is far safer than treating it. A proactive approach includes:

  • Preconception counseling: Optimize glycemic control before pregnancy. Target A1C levels below 6.5% when possible.
  • Frequent glucose monitoring: Check blood glucose at least 6-8 times per day during pregnancy, including fasting, postprandial, and bedtime values.
  • Ketone testing: Women should have urine or blood ketone test strips available and know when to use them—during illness, when glucose is above 250 mg/dL, or when symptoms of DKA appear.
  • Insulin dose adjustment: Insulin requirements rise significantly in the second and third trimesters. Frequent dose adjustments based on glucose trends are necessary.
  • Sick-day management plans: Pregnant women need written instructions for managing fever, infection, and gastrointestinal illness, including when to take supplemental insulin and when to present for care.
  • Avoiding insulin omission: Even a single missed dose can trigger DKA in a vulnerable patient. Education about the consequences of skipping doses is critical.

Prognosis and Recovery

With prompt recognition and appropriate treatment, the prognosis for both mother and baby is good. Most women recover fully within 24 to 48 hours of initiating therapy. Fetal outcomes depend on the severity and duration of acidosis at presentation. Early fetal heart rate abnormalities usually resolve as the mother's metabolic status improves. A healthy term delivery following a DKA episode is possible when glycemic control is restored and the underlying trigger is managed.

Women who have had one episode of DKA during pregnancy are at increased risk for recurrence, particularly if the same risk factors persist. Close follow-up with an endocrinologist and maternal-fetal medicine specialist is essential for the remainder of the pregnancy and postpartum period, when insulin sensitivity rapidly changes again.

Key Takeaways for Clinicians and Patients

DKA in pregnancy is a preventable and treatable emergency, but it demands awareness, preparation, and immediate action. Pregnant women with diabetes should be educated about the subtle ways DKA can present, especially the possibility of euglycemic DKA. Clinicians should maintain a low threshold for laboratory evaluation when symptoms are equivocal. The partnership between a well-informed patient and a responsive care team is the foundation of favorable outcomes.

For further reading and clinical guidelines, the American Diabetes Association publishes comprehensive Standards of Care that include specific recommendations for diabetes management in pregnancy. The National Institutes of Health also offers patient-oriented resources on DKA recognition. Clinicians can refer to the American College of Obstetricians and Gynecologists practice bulletins for evidence-based recommendations on diabetes in pregnancy.